Qingyu Luo

Statistics

Publications

Citations

760

H-Index

Active since

2018

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

National Cancer Center

Harvard University

Dana-Farber Cancer Institute

Zhejiang Cancer Hospital

Qingyu Luo is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in molecular oncology, oncology, and cancer cell signaling.

ORCID

Publications per year

2018–2024

Publications

OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation

Qingyu Luo, Xiaowei Wu, Pengfei Zhao et al. · Advanced Science · 2021 · 111 citations · Full text

Life Sciences, Biochemistry, Cell Biology +16

MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer

Xiaowei Wu, Qingyu Luo, Pengfei Zhao et al. · Proceedings of the National Academy of Sciences · 2019 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +11

JOSD1 inhibits mitochondrial apoptotic signalling to drive acquired chemoresistance in gynaecological cancer by stabilizing MCL1

Xiaowei Wu, Qingyu Luo, Pengfei Zhao et al. · Cell Death and Differentiation · 2019 · 87 citations · Full text

Medicine, Cancer Biology, Oncology +12

ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2

Qingyu Luo, Xiaowei Wu, Yiping Zhang et al. · Cancer Letters · 2018 · 58 citations

Medicine, Cancer Biology, Oncology +17

TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma

Qingyu Luo, Xiaowei Wu, Yabing Nan et al. · Cell Reports · 2020 · 55 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +16

1–5 of 17